Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • November 2012
  • Supplement
  • HBS Case Collection

Amylin Pharmaceuticals (B)

By: Richard G. Hamermesh and Carin-Isabel Knoop
  • Format:Print
  • | Language:English
  • | Pages:7
ShareBar

Abstract

Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the company remained unprofitable as sales plateaued. The small pharmaceutical company was hurt by long delays in bringing Bydureon, a once-a-week version of Byetta, to market, which allowed a competitor time to establish itself in the once-a-week market. Amylin also failed to develop a marketable anti-obesity drug after the purchase of the promising leptin molecule from Amgen, Inc. In 2012, Amylin was acquired by Bristol-Myers Squibb for $5.3 billion.

Keywords

Pharmaceuticals; Bristol-Myers Squibb; Health Care and Treatment; Pharmaceutical Industry; United States

Citation

Hamermesh, Richard G., and Carin-Isabel Knoop. "Amylin Pharmaceuticals (B)." Harvard Business School Supplement 813-091, November 2012.
  • Purchase

About The Author

Richard G. Hamermesh

→More Publications

More from the Authors

    • January 17, 2022
    • Harvard Business Review (website)

    Reducing Racial Disparities in Cancer Outcomes

    By: Kathy Giusti and Richard G. Hamermesh
    • October 2021
    • Faculty Research

    Diversifying P&G's Supplier Base (B)

    By: Kris Ferreira, Kym Lew Nelson, Carin-Isabel Knoop and Sarah Mehta
    • October 2021
    • Faculty Research

    Diversifying P&G's Supplier Base (A)

    By: Kris Ferreira, Kym Lew Nelson, Carin-Isabel Knoop and Sarah Mehta
More from the Authors
  • Reducing Racial Disparities in Cancer Outcomes By: Kathy Giusti and Richard G. Hamermesh
  • Diversifying P&G's Supplier Base (B) By: Kris Ferreira, Kym Lew Nelson, Carin-Isabel Knoop and Sarah Mehta
  • Diversifying P&G's Supplier Base (A) By: Kris Ferreira, Kym Lew Nelson, Carin-Isabel Knoop and Sarah Mehta
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College